ARCHIVE

• SSP Initiates Clinical Study on Antibacterial Eye Drops in US
  February 24, 2003

• Sankyo, Fujisawa to Market Aventis' Telithromycin
  February 24, 2003

• Testing Conditions Announced for 23rd Quality Reevaluation
  February 24, 2003

• JSC Recommends Discontinuation of Intradermal Test for Antibacterials
  February 24, 2003

• Kyowa Hakko Sets Up Antibody Biz House
  February 24, 2003

• Physicians with Knowledge of Both Western and Oriental Medicine Needed: Kampo Symposium
  February 24, 2003

• Eli Lilly Conducts Trial on Switching from Typical to Atypical Antipsychotic Drugs
  February 24, 2003

• Pharma SNP Consortium to Complete Activities in May
  February 24, 2003

• Singulair's Share Up Since Approval of Long-term Prescription: Banyu
  February 24, 2003

• PRESS SEMINAR
  February 24, 2003

• Novo Nordisk Pharma to Focus Harder on Diabetes: President Moore
  February 24, 2003

• RESEARCH & DEVELOPMENT NEWS IN BRIEF
  February 24, 2003

• Sales of Anti-allergic Talion Set to Double in FY2002: Tanabe
  February 24, 2003

• ESRI Report Recommends Unification of Social Insurance Programs
  February 24, 2003

• MEDICAL DEVICE NEWS IN BRIEF
  February 24, 2003

• Overseas Growth a Major Priority: Kyorin's President
  February 24, 2003

• National Burden Rate to Drop to 36.1% in FY2003
  February 24, 2003

• Matsumotokiyoshi Ties Up with Itayama Medico of Yamanashi
  February 24, 2003

• 10 Wholesalers to Be Surcharged for Violation of Antimonopoly Act
  February 24, 2003

• List of Drugs Announced for 24th Quality Reevaluation
  February 24, 2003

ページ

• « 先頭
• ‹ Prev
• …
• 616
• 617
• 618
• 619
• 620
• 621
• 622
• 623
• 624
• …
• Next ›
• 最終 »